About this trial

Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.

Eligibility criteria

Qualifiers

Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record

Less than 6 years old at the time of study enrollment

Patient at Boston Children's Hospital

Disqualifiers

Genetic cause of NE already identified

Deceased prior to enrollment

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

300 Participants
are grouped into 1 trial group

Locations

1
Boston Children's Hospital02115, BostonMassachusetts, United States

Sponsors and collaborators

Boston Children's Hospital

Lead sponsor